Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Transcode Therapeutics Inc (RNAZ)

Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,805
  • Shares Outstanding, K 17,266
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,550 K
  • EBIT $ -15 M
  • EBITDA $ -14 M
  • 60-Month Beta 0.65
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.43
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.55
  • Most Recent Earnings $-0.16 on 11/14/24
  • Next Earnings Date 11/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.30
  • Number of Estimates 1
  • High Estimate -0.30
  • Low Estimate -0.30
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3130 +21.41%
on 11/12/24
0.7700 -50.65%
on 10/23/24
-0.2400 (-38.71%)
since 10/21/24
3-Month
0.2226 +70.71%
on 09/05/24
0.8000 -52.50%
on 10/11/24
+0.1004 (+35.91%)
since 08/21/24
52-Week
0.2160 +75.93%
on 08/14/24
18.6640 -97.96%
on 11/30/23
-8.8360 (-95.88%)
since 11/21/23

Most Recent Stories

More News
TransCode Therapeutics Open Letter to Shareholders

RNAZ : 0.3800 (+13.03%)
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

RNAZ : 0.3800 (+13.03%)
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

RNAZ : 0.3800 (+13.03%)
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology

RNAZ : 0.3800 (+13.03%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

BMY : 58.23 (+0.60%)
ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.3800 (+13.03%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...

ONC.TO : 1.37 (-2.14%)
ONCY : 0.9800 (-1.85%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.3800 (+13.03%)
BMY : 58.23 (+0.60%)
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NYSE:BMY),(NASDAQ:RXDS),(NASDAQ:RNAZ) EQNX::TICKER_END

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
GILD : 89.76 (+1.27%)
RXDX : 199.92 (+0.09%)
RNAZ : 0.3800 (+13.03%)
BMY : 58.23 (+0.60%)
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - According to a report from Global Market Insights the Breast Cancer Therapeutics Market size, which...

ONC.TO : 1.37 (-2.14%)
ONCY : 0.9800 (-1.85%)
GILD : 89.76 (+1.27%)
BMY : 58.23 (+0.60%)
RXDX : 199.92 (+0.09%)
RNAZ : 0.3800 (+13.03%)
Biotech Sees Massive Rally On Major Announcement

A Boston-based %Biotech company caught the attention of the trading community on Wednesday after it was announced that the company withdrew the Registration Statement on Form S-1 it filed with the U.S....

RNAZ : 0.3800 (+13.03%)
Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MACK),(NASDAQ:NRBO),(NYSE:MRK),(NASDAQ:RNAZ), EQNX::TICKER_END

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
MACK : 15.13 (unch)
NRBO : 2.35 (-2.08%)
MRK : 99.86 (+2.48%)
RNAZ : 0.3800 (+13.03%)

Business Summary

TransCode Therapeutics is an emerging RNA oncology company. Its platform of investigational drug candidates is dedicated to improving patient outcomes encompassing a variety of tumor types. The company's lead therapeutic candidate includes TTX-MC138. TransCode Therapeutics is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 0.4587
2nd Resistance Point 0.4233
1st Resistance Point 0.4017
Last Price 0.3800
1st Support Level 0.3447
2nd Support Level 0.3093
3rd Support Level 0.2877

See More

52-Week High 18.6640
Fibonacci 61.8% 11.6169
Fibonacci 50% 9.4400
Fibonacci 38.2% 7.2631
Last Price 0.3800
52-Week Low 0.2160

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar